Archive - April 2018
Keytruda gains NICE clearance in first line bladder cancer
Intel and pharma look to develop blockchain technology that tracks opioids
FDA green lights placenta-based radiation treatment
CHMP backs first-line use for AZ’s Tagrisso in lung cancer
Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more
Allergan’s oral migraine drug closer to US filing
Sandoz targets digital therapeutics
US priority review for Sanofi, Regeneron’s cemiplimab